CC BY-NC-ND 4.0 · Synlett
DOI: 10.1055/s-0043-1763751
letter

Synthesis of α-Phenyl β-Enamino γ-Sultims: the New Horizon of the CSIC Reaction

Yaroslav O. Chuchvera
a   Enamine Ltd., Winston Churchill Street 78, Kyiv 02094, Ukraine   URL: www.enamine.net
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
,
Valentyna Tararina
a   Enamine Ltd., Winston Churchill Street 78, Kyiv 02094, Ukraine   URL: www.enamine.net
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
,
Inna Chuchvera
a   Enamine Ltd., Winston Churchill Street 78, Kyiv 02094, Ukraine   URL: www.enamine.net
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
,
Eugeniy N. Ostapchuk
a   Enamine Ltd., Winston Churchill Street 78, Kyiv 02094, Ukraine   URL: www.enamine.net
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
,
Maria V. Popova
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
c   Max Planck Institute for Polymer Research, Ackermannweg 10, 55128 Mainz, Germany
,
Svitlana V. Shishkina
d   SSI ‘Institute for Single Crystals’ National Academy of Science of Ukraine, Nauky Avenue 60, Kharkiv 61001, Ukraine
,
Yulian M. Volovenko
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
,
a   Enamine Ltd., Winston Churchill Street 78, Kyiv 02094, Ukraine   URL: www.enamine.net
b   Taras Shevchenko National University of Kyiv, Volodymyrska Street 60, Kyiv 01033, Ukraine
› Author Affiliations
The work was funded by Enamine Ltd. Additional funding from the Ministry of Education and Science of Ukraine, Grant No. 0122U001809 (22БФ037-07) is also acknowledged.
 


Abstract

Herein, we report the novel strategy for the synthesis of 4-enamino-5-phenyl-2,3-dihydroisothiazole 1-oxides (in other words α-phenyl β-enamino γ-sultims) based on the CSIC reaction. Particularly, readily available α-amino nitriles (the Strecker products) reacted with benzyl sulfinyl chloride to give the corresponding sulfinamides, which upon treatment with excess of LiHMDS converted into the target α-phenyl β-enamino γ-sultims. The method works well and tolerates strained 3- and 4-membered spirocyclic substituents. A preliminary in silico study indicated that the γ-sultim scaffold can be considered a promising pharmacophore template.


#

The application of novel and uncommon structural motifs in lead-oriented synthesis[1] opens up new avenues for the development of innovative pharmaceuticals. The unique structural frameworks allow the creation of new chemical entities (NCE) for tackling previously intractable diseases and drug-resistant pathogens. In this regard, sulfinamides[2] and their cyclic congeners, regarded as a separate class, sultims,[3] can be considered as chiral bioisosteres of carboxamides and lactams, respectively.[4]

Despite γ-sultims having been known since the early 1920s,[5] they have triggered attention as novel pharmacological templates only in the last decades. This is especially indicative for (en)amino derivatives. The antibacterial candidate[6] and gastric secretion inhibitors[7] may serve as examples (Figure [1]).

Zoom Image
Figure 1 Biologically active β-(en)amino γ-sultims

Surprisingly, only two approaches to the construction of β-enamino γ-sultim framework have been reported to date. The first one is underlain on the base-mediated rearrangement of penicillin sulfoxides (Scheme [1], A).[8a] [b] However, this strategy appeared synthetically useless since it provided the complex mixture of product so that the desired sultims were isolated in low yields through the tedious purification procedures. The second approach looked more reliable in that it implied the oxidation of the appropriately substituted isothiazolones with mCPBA (Scheme [1], B).[8] With that, neither general procedures for both approaches nor isolated yields of pure products have been provided. The present work is devoted to the synthesis of α-phenyl β-enamino γ-sultims through the LiHMDS-mediated cyclization of N-sulfinylated α-amino nitriles (Scheme [1], C).

While syntheses for sultams (cyclic sulfonamides) are relatively common,[9] sultims still have remained an underrepresented class that can be accessed through the quite limited set of synthetic strategies.[3] [10] Recently we have described the synthesis of differently substituted/functionalized β-enamino γ-sultams[11] through the carbanion-mediated sulfonate (or sulfonamide) intermolecular coupling and intramolecular cyclization (CSIC) reaction.[12] Inspired by this, we assumed that the logic inherent in the above synthetic strategy can be extended to access similarly substituted/functionalized β-enamino γ-sultims. In turn, the direct precursors for the sulfa-Thorpe cyclization can be prepared by the simple sulfinylation of readily available N-monosubstituted α-amino nitriles, the Strecker products (Scheme [2]).

Zoom Image
Scheme 1 Synthetic approaches toward β-enamino γ-sultims
Zoom Image
Scheme 2 Retrosynthetic disconnection for the assembly of α-phenyl β-enamino γ-sultims

We initiated our study with the synthesis of the model sulfinylation agent – benzyl sulfinyl chloride (3) adopting the literature method on the oxidation of 1,2-dibenzyldisulfane (4) with SOCl2 (Scheme [3]).[13] [14] It should be taken into account that the residual amount of both SO2Cl2 and SOCl2 led to a significant loss of yield on the next sulfinylation step. Therefore, it is quite important to rid sulfinyl chloride 3 of these impurities as thoroughly as possible.

Zoom Image
Scheme 3 Synthesis of benzyl sulfinyl chloride (3)

With the freshly prepared benzyl sulfinyl chloride (3) in hand, a set of α-amino nitriles 5 was involved in the sulfinylation step, and the corresponding linear sulfinamides 2 were isolated in fair to good yields (Table [1]).[15] [16] It should be noted that the crude product can be used in the next step so that up to 20% of impurities are permissible. The overall yields of the target γ-sultims (starting from 5ac) were comparable to those when purified precursors 2ae were involved in the final cyclization step.

Next, we set out to optimize the reaction conditions for the cyclization step. Initially, we faced synthetically unacceptable yields (not exceeding 10%) when using slight excess (up to 15%) of LiHMDS. After extensive exploration, conditions utilizing 4.5 equivalents of LiHMDS resulted in a dramatic improvement in the yield of the target α-phenyl β-enamino γ-sultims 1 (Table [1]). Presumably, this arises from the zwitterionic form of the S=O double bond, which forms a 1:1 complex with LiHDMS, in this way precluding the abstraction of the proton from the (S=O)CH2Ph fragment. Therefore, extra equivalents of the base are required to move the equilibrium reaction towards the formation of the carbanion. It should be also taken into account that a stoichiometric amount of LiHMDS remains coordinated with the sulfinyl group even after the cyclization reaction has taken place (Scheme [4]).

Zoom Image
Scheme 4 Coordination of LiHDMS with the sulfinyl group of the precursor 2, intermediate carbanion, and the target β-enamino γ-sultim 1

These optimized reaction conditions allowed us to convert sulfinamide precursors 2 into the desired α-phenyl β-enamino γ-sultims 1 with synthetically valuable yields (Table [1]).[17] [18] It transpired that the nature of the substituent in the α-position of amino nitriles 5 had some impact on the yield of both the linear sulfinamides 2 and target products. Thus, sultims 1b,c possessing strained 3- and 4-membered spirocyclic substituents were isolated in lower yields than their unstrained counterparts 1a,d,e (Table [1]).

The presence of the sulfur(IV) atom endowed precursors 2 and β-enamino γ-sultims 1 with chirality and caused a chemical anisotropy shift of the signals of the (spiro)alkyl substituent in NMR spectra (attributable to deshielding effect by S=O and to shielding one by the lone pair). For instance, two methyl groups in the 3rd position of sultim 1a exhibited a moderate chemical anisotropy shift both in 1H (Δδ = 0.22 ppm) and 13C (Δδ = 2.9 ppm) NMR spectra.

The structure of β-enamino γ-sultim 1c was established unambiguously by the X-ray crystal structure analysis (Figure [2]).[19]

Table 1 Synthesis of α-Phenyl β-Enamino γ-Sultims 1

Entry

Starting α-amino nitrile 5

N-sulfinylated α-amino nitrile 2

Yield (%)

β-Enamino γ-sultim 1

Yield (%)

1

70

80

2

49

52

3

55

65

4

53

73

5

62

84

Zoom Image
Figure 2 Molecular structure of α-phenyl β-enamino γ-sultim 1c according to results of X-ray crystal-structure analysis. Thermal ellipsoids are shown at the 50% probability level.

To further demonstrate the potential utility of β-enamino γ-sultim scaffold we estimated their probable biological activity resorting to in silico methods. To accomplish this, molecular docking of sultim 1c into the aldehyde dehydrogenase ALDH1A1 (pdb id: 5L2M) active site was performed. The docking grid was established centered on the co-crystallized ligand (BUC11).[20] The obtained results showed that 1c has predicted affinity to ALDH1A1 (Figure [3]). The recent studies showed that ALDH1A1 inhibitors acted as the tumor suppressors in certain cancers and therefore ALDH1A1-targeted therapy has become widespread in cancer treatment.[21] Apart from that, ALDH1A1 downregulation in retinal Müller glia could contribute to the inner blood retinal barrier (iBRB) breakdown during diabetic retinopathy, the main cause of vision loss in this disease.[22]

In conclusion, the CSIC reaction strategy appeared as an appropriate and, apparently, the most reliable tool for the construction of β-enamino γ-sultim framework. The method worked well and tolerated strained 3- and 4-membered spirocyclic substituents. Having developed the synthesis of α-phenyl β-enamino γ-sultims, we would extend this protocol to other substituted and α-functionalized sultims. Owing to low molecular weight, sp 3-enrichment, and conformational restriction, β-enamino γ-sultims meet the criteria for lead-oriented synthesis.[1a] Preliminary in silico study indicated that γ-sultim scaffold can be considered a promising template and therefore might be useful for early drug discovery programs.

Zoom Image
Figure 3 3D binding mode of sultim 1c in the active site of ALDH1A1

#

Conflict of Interest

The authors declare no conflict of interest.

Acknowledgment

The authors thank Dr. Yuliia Satska for the chromatographic purification of the discussed compounds and Prof. Andrey A. Tolmachev for his encouragement and support.

Supporting Information

  • References and Notes

    • 1a Nadin A, Hattotuwagama C, Churcher I. Angew. Chem. Int. Ed. 2012; 51: 1114
    • 1b Doveston R, Marsden S, Nelson A. Drug Discovery Today 2014; 19: 813
    • 2a Zhang Q, Xi J, Ze H, Qingle Z. Synthesis 2021; 53: 2570
    • 2b Yin X, Zhang Q, Zeng Q. Organics 2023; 4: 173
    • 2c Wojaczyńska E, Wojaczyński J. Chem. Rev. 2020; 120: 4578
    • 2d Achuenu C, Carret S, Poisson J, Berthiol F. Eur. J. Org. Chem. 2020; 5901
    • 2e Lo PK. T, Oliver GA, Willis MC. J. Org. Chem. 2020; 85: 5753
    • 2f Cao Y, Abdolmohammadi S, Ahmadi R, Issakhov A, Ebadi AG, Vessally E. RSC Adv. 2021; 11: 32394
    • 2g Davis FA. J. Org. Chem. 2006; 71: 8993
  • 3 Dobrydnev AV, Popova MV, Volovenko YM. Chem. Rec. 2024; 24: e202300221
  • 5 Reißert A. Ber. Dtsch. Chem. Ges. 1922; 55: 858
  • 6 Chen Z, Demuth TP, Wireko FC. Bioorg. Med. Chem. Lett. 2001; 11: 2111
  • 7 Britcher SF, Lumma WC. J. US5171860A, 1992
    • 8a Kamiya T, Teraji T, Hashimoto M, Nakaguchi O, Oku T. J. Am. Chem. Soc. 1975; 97: 5020
    • 8b Fukumura M, Hamma N, Nakagome T. Tetrahedron Lett. 1975; 16: 4123
    • 8c Morin RB, Gordon EM, Lake JR. Tetrahedron Lett. 1973; 14: 5213
    • 9a Rassadin VA, Grosheva DS, Tomashevskii AA, Sokolov VV. Chem. Heterocycl. Compd. 2013; 49: 39
    • 9b Popova MV, Dobrydnev AV. Chem. Heterocycl. Compd. 2017; 53: 492
    • 9c Debnath S, Mondal S. Eur. J. Org. Chem. 2018; 933
  • 10 Dittmer DC, Hoey MD. In The Chemistry of Sulphinic Acids, Esters and Derivatives . Patai S. John Wiley & Sons; Chichester: 1990: 239
    • 11a Popova MV, Dobrydnev AV, Dyachenko MS, Duhayon C, Listunov D, Volovenko YM. Monatsh. Chem. 2017; 148: 939
    • 11b Dobrydnev AV, Vashchenko BV, Konovalova IS, Bisikalo KO, Volovenko YM. Monatsh. Chem. 2018; 149: 1827
    • 11c Dyachenko MS, Dobrydnev AV, Volovenko YM. Mol. Diversity 2018; 22: 919
    • 11d Dyachenko MS, Dobrydnev AV, Chuchvera YO, Shishkina SV, Volovenko YM. Chem. Heterocycl. Compd. 2020; 56: 386
    • 11e Omelian TV, Dobrydnev AV, Utchenko OY, Ostapchuk EN, Konovalova IS, Volovenko YM. Monatsh. Chem. 2020; 151: 1759
    • 11f Dobrydnev AV, Popova MV, Yatsymyrskyi AV, Shishkina SV, Chuchvera YO, Volovenko YM. J. Mol. Struct. 2024; 1295: 136745
    • 12a Marco JL, Ingate ST, Chinchón PM. Tetrahedron 1999; 55: 7625
    • 12b Marco JL, Ingate ST, Jaime C, Beá I. Tetrahedron 2000; 56: 2523
    • 12c Postel D, Van Nhien AN, Marco JL. Eur. J. Org. Chem. 2003; 3713
    • 12d Domínguez L, Nguyen Van Nhien A, Tomassi C, Len C, Postel D, Marco-Contelles J. J. Org. Chem. 2004; 69: 843
    • 12e Dobrydnev AV, Marco-Contelles J. Eur. J. Org. Chem. 2021; 1229
  • 13 Youn J.-H, Herrmann R. Tetrahedron Lett. 1986; 27: 1493
  • 14 Benzyl Sulfinyl Chloride (3) The solution of 1,2-dibenzyldisulfane (4, 24.6 g, 100 mmol) and AcOH (12.6 g, 12 mL, 210 mmol) in CH2Cl2 (250 mL) was cooled to –40 °C followed by dropwise addition of freshly distilled SO2Cl2 (43.2 g, 25.9 mL, 320 mmol) maintaining the above temperature. The resulting mixture was stirred at –40 °C for 30 min, then warmed to rt, and stirred at this temperature for another 30 min. Then the reaction mixture was carefully heated to 35–40 °C (Caution! Violent gas release). After gas evolution had ceased, the reaction mixture was evaporated at reduced pressure maintaining the internal temperature below 35 °C, and then dried in a vacuum (0.5 mmHg) with stirring at rt for 2 h. Thus obtained sulfinyl chloride 3 (ca. 33 g, 95% crude yield) was used in the sulfinylation step without additional purification, and the rest was stored at 4 °C.
  • 15 General Procedure for the Synthesis of Sulfinamides 2a–c PhCH2SOCl (3, 9.6 g, 55 mmol, 1.1 equiv) was added dropwise to the stirred cold (–20 °C) solution of α-amino nitrile 5ae (50 mmol, 1 equiv) and DIPEA (14.2 g, 19.2 mml, 110 mmol, 2.2 equiv) in anhydrous CH2Cl2 (100 mL). After the reagent had been added the reaction mixture was stirred at –20 °C for 30 min whereupon was left to react overnight allowing to equilibrate to rt. The resulting reaction mixture was filtered, the filtrate was evaporated at reduced pressure and redissolved in EtOAc (100 mL). The organic layer was sequentially washed with saturated aq. NaHCO3 (1 × 10 mL) and brine (1 × 10 mL), dried (Na2SO4), and evaporated at reduced pressure to give the title product 2ae. Thus obtained sulfinamides were pure enough to be used in subsequent cyclization step without additional purification. If necessary, sulfinamides 2ae can be purified by silica gel flash chromatography (gradient elution from hexanes–t-BuOMe (1:1) to t-BuOMe).
  • 16 N-(2-Cyanopropan-2-yl)-N-methyl-1-phenylmethanesulfinamide (2a) From 5a (4.9 g); yield 8.27 g (35 mmol, 70%); yellow oil. 1H NMR (400 MHz, CDCl3): δ = 7.35–7.23 (m, 3 H), 7.18 (d, J = 7.6 Hz, 2 H), 3.94 (dd, J = 13.0, 9.6 Hz, 2 H), 2.81 (s, 3 H), 1.40 (s, 3 H), 1.32 (s, 3 H). 13C NMR (126 MHz, CDCl3): δ = 130.1, 130.0, 128.9, 128.3, 120.5, 60.2, 55.8, 27.1, 26.5, 25.5. MS (APCI): m/z = 237 [М + Н]+.
  • 17 General Procedure for the Synthesis of β-Enamino γ-Sultims 1a–e The solution of LiHMDS (15 g, 90 mmol, 4.5 equiv) in THF (85 mL) was added dropwise to the stirred cold (–60 °C) solution of sulfinamide 2ae (20 mmol) in THF (40 mL) under Ar atmosphere. After the reagent had been added the reaction mixture was stirred at –60 °C for 30 min whereupon was heated to 0 °C within 90 min. After this time the reaction mixture was quenched by pouring it into cold (0 °C) saturated aq. NH4Cl (100 mL) followed by extraction with t-BuOMe (3 × 50 mL). The combined organic layer was dried (Na2SO4) and evaporated at reduced pressure to give the target product 1ae. Thus obtained β-enamino γ-sultims were pure enough and if necessary were further purified by silica gel flash chromatography (gradient elution from hexanes–t-BuOMe (1:1) to t-BuOMe).
  • 18 4-Amino-2,3,3-trimethyl-5-phenyl-2,3-dihydroisothiazole 1-oxide (1a) From 2a (4.73 g); yield 3.78 g (16 mmol, 80%); white solid; mp 92–94 °C. 1H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 7.5 Hz, 2 H), 7.36 (t, J = 7.5 Hz, 2 H), 7.22 (t, J = 7.5 Hz, 1 H), 4.36 (s, 2 H), 2.85 (s, 3 H), 1.54 (s, 3 H), 1.31 (s, 3 H). 13C NMR (101 MHz, CDCl3): δ = 155.2, 131.8, 129.2, 128.0, 127.0, 111.8, 69.9, 28.0, 27.0, 24.1. MS (APCI): m/z = 237 [М + Н]+.
  • 19 CCDC 2332756 contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
  • 20 Buchman CD, Hurley TD. J. Med. Chem. 2017; 60: 2439
  • 21 Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. Front. Oncol. 2022; 12: 918778
    • 22a McDowell RE, McGahon MK, Augustine J, Chen M, McGeown JG, Curtis TM. Invest. Opthalmol. Visual Sci. 2016; 57: 4762
    • 22b Karan BM, Little K, Augustine J, Stitt AW, Curtis TM. Antioxidants 2023; 12: 1466

Corresponding Author

Alexey V. Dobrydnev
Enamine Ltd.
Winston Churchill Street 78, Kyiv 02094
Ukraine   

Publication History

Received: 14 February 2024

Accepted after revision: 18 March 2024

Article published online:
15 April 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

  • References and Notes

    • 1a Nadin A, Hattotuwagama C, Churcher I. Angew. Chem. Int. Ed. 2012; 51: 1114
    • 1b Doveston R, Marsden S, Nelson A. Drug Discovery Today 2014; 19: 813
    • 2a Zhang Q, Xi J, Ze H, Qingle Z. Synthesis 2021; 53: 2570
    • 2b Yin X, Zhang Q, Zeng Q. Organics 2023; 4: 173
    • 2c Wojaczyńska E, Wojaczyński J. Chem. Rev. 2020; 120: 4578
    • 2d Achuenu C, Carret S, Poisson J, Berthiol F. Eur. J. Org. Chem. 2020; 5901
    • 2e Lo PK. T, Oliver GA, Willis MC. J. Org. Chem. 2020; 85: 5753
    • 2f Cao Y, Abdolmohammadi S, Ahmadi R, Issakhov A, Ebadi AG, Vessally E. RSC Adv. 2021; 11: 32394
    • 2g Davis FA. J. Org. Chem. 2006; 71: 8993
  • 3 Dobrydnev AV, Popova MV, Volovenko YM. Chem. Rec. 2024; 24: e202300221
  • 5 Reißert A. Ber. Dtsch. Chem. Ges. 1922; 55: 858
  • 6 Chen Z, Demuth TP, Wireko FC. Bioorg. Med. Chem. Lett. 2001; 11: 2111
  • 7 Britcher SF, Lumma WC. J. US5171860A, 1992
    • 8a Kamiya T, Teraji T, Hashimoto M, Nakaguchi O, Oku T. J. Am. Chem. Soc. 1975; 97: 5020
    • 8b Fukumura M, Hamma N, Nakagome T. Tetrahedron Lett. 1975; 16: 4123
    • 8c Morin RB, Gordon EM, Lake JR. Tetrahedron Lett. 1973; 14: 5213
    • 9a Rassadin VA, Grosheva DS, Tomashevskii AA, Sokolov VV. Chem. Heterocycl. Compd. 2013; 49: 39
    • 9b Popova MV, Dobrydnev AV. Chem. Heterocycl. Compd. 2017; 53: 492
    • 9c Debnath S, Mondal S. Eur. J. Org. Chem. 2018; 933
  • 10 Dittmer DC, Hoey MD. In The Chemistry of Sulphinic Acids, Esters and Derivatives . Patai S. John Wiley & Sons; Chichester: 1990: 239
    • 11a Popova MV, Dobrydnev AV, Dyachenko MS, Duhayon C, Listunov D, Volovenko YM. Monatsh. Chem. 2017; 148: 939
    • 11b Dobrydnev AV, Vashchenko BV, Konovalova IS, Bisikalo KO, Volovenko YM. Monatsh. Chem. 2018; 149: 1827
    • 11c Dyachenko MS, Dobrydnev AV, Volovenko YM. Mol. Diversity 2018; 22: 919
    • 11d Dyachenko MS, Dobrydnev AV, Chuchvera YO, Shishkina SV, Volovenko YM. Chem. Heterocycl. Compd. 2020; 56: 386
    • 11e Omelian TV, Dobrydnev AV, Utchenko OY, Ostapchuk EN, Konovalova IS, Volovenko YM. Monatsh. Chem. 2020; 151: 1759
    • 11f Dobrydnev AV, Popova MV, Yatsymyrskyi AV, Shishkina SV, Chuchvera YO, Volovenko YM. J. Mol. Struct. 2024; 1295: 136745
    • 12a Marco JL, Ingate ST, Chinchón PM. Tetrahedron 1999; 55: 7625
    • 12b Marco JL, Ingate ST, Jaime C, Beá I. Tetrahedron 2000; 56: 2523
    • 12c Postel D, Van Nhien AN, Marco JL. Eur. J. Org. Chem. 2003; 3713
    • 12d Domínguez L, Nguyen Van Nhien A, Tomassi C, Len C, Postel D, Marco-Contelles J. J. Org. Chem. 2004; 69: 843
    • 12e Dobrydnev AV, Marco-Contelles J. Eur. J. Org. Chem. 2021; 1229
  • 13 Youn J.-H, Herrmann R. Tetrahedron Lett. 1986; 27: 1493
  • 14 Benzyl Sulfinyl Chloride (3) The solution of 1,2-dibenzyldisulfane (4, 24.6 g, 100 mmol) and AcOH (12.6 g, 12 mL, 210 mmol) in CH2Cl2 (250 mL) was cooled to –40 °C followed by dropwise addition of freshly distilled SO2Cl2 (43.2 g, 25.9 mL, 320 mmol) maintaining the above temperature. The resulting mixture was stirred at –40 °C for 30 min, then warmed to rt, and stirred at this temperature for another 30 min. Then the reaction mixture was carefully heated to 35–40 °C (Caution! Violent gas release). After gas evolution had ceased, the reaction mixture was evaporated at reduced pressure maintaining the internal temperature below 35 °C, and then dried in a vacuum (0.5 mmHg) with stirring at rt for 2 h. Thus obtained sulfinyl chloride 3 (ca. 33 g, 95% crude yield) was used in the sulfinylation step without additional purification, and the rest was stored at 4 °C.
  • 15 General Procedure for the Synthesis of Sulfinamides 2a–c PhCH2SOCl (3, 9.6 g, 55 mmol, 1.1 equiv) was added dropwise to the stirred cold (–20 °C) solution of α-amino nitrile 5ae (50 mmol, 1 equiv) and DIPEA (14.2 g, 19.2 mml, 110 mmol, 2.2 equiv) in anhydrous CH2Cl2 (100 mL). After the reagent had been added the reaction mixture was stirred at –20 °C for 30 min whereupon was left to react overnight allowing to equilibrate to rt. The resulting reaction mixture was filtered, the filtrate was evaporated at reduced pressure and redissolved in EtOAc (100 mL). The organic layer was sequentially washed with saturated aq. NaHCO3 (1 × 10 mL) and brine (1 × 10 mL), dried (Na2SO4), and evaporated at reduced pressure to give the title product 2ae. Thus obtained sulfinamides were pure enough to be used in subsequent cyclization step without additional purification. If necessary, sulfinamides 2ae can be purified by silica gel flash chromatography (gradient elution from hexanes–t-BuOMe (1:1) to t-BuOMe).
  • 16 N-(2-Cyanopropan-2-yl)-N-methyl-1-phenylmethanesulfinamide (2a) From 5a (4.9 g); yield 8.27 g (35 mmol, 70%); yellow oil. 1H NMR (400 MHz, CDCl3): δ = 7.35–7.23 (m, 3 H), 7.18 (d, J = 7.6 Hz, 2 H), 3.94 (dd, J = 13.0, 9.6 Hz, 2 H), 2.81 (s, 3 H), 1.40 (s, 3 H), 1.32 (s, 3 H). 13C NMR (126 MHz, CDCl3): δ = 130.1, 130.0, 128.9, 128.3, 120.5, 60.2, 55.8, 27.1, 26.5, 25.5. MS (APCI): m/z = 237 [М + Н]+.
  • 17 General Procedure for the Synthesis of β-Enamino γ-Sultims 1a–e The solution of LiHMDS (15 g, 90 mmol, 4.5 equiv) in THF (85 mL) was added dropwise to the stirred cold (–60 °C) solution of sulfinamide 2ae (20 mmol) in THF (40 mL) under Ar atmosphere. After the reagent had been added the reaction mixture was stirred at –60 °C for 30 min whereupon was heated to 0 °C within 90 min. After this time the reaction mixture was quenched by pouring it into cold (0 °C) saturated aq. NH4Cl (100 mL) followed by extraction with t-BuOMe (3 × 50 mL). The combined organic layer was dried (Na2SO4) and evaporated at reduced pressure to give the target product 1ae. Thus obtained β-enamino γ-sultims were pure enough and if necessary were further purified by silica gel flash chromatography (gradient elution from hexanes–t-BuOMe (1:1) to t-BuOMe).
  • 18 4-Amino-2,3,3-trimethyl-5-phenyl-2,3-dihydroisothiazole 1-oxide (1a) From 2a (4.73 g); yield 3.78 g (16 mmol, 80%); white solid; mp 92–94 °C. 1H NMR (400 MHz, CDCl3): δ = 7.47 (d, J = 7.5 Hz, 2 H), 7.36 (t, J = 7.5 Hz, 2 H), 7.22 (t, J = 7.5 Hz, 1 H), 4.36 (s, 2 H), 2.85 (s, 3 H), 1.54 (s, 3 H), 1.31 (s, 3 H). 13C NMR (101 MHz, CDCl3): δ = 155.2, 131.8, 129.2, 128.0, 127.0, 111.8, 69.9, 28.0, 27.0, 24.1. MS (APCI): m/z = 237 [М + Н]+.
  • 19 CCDC 2332756 contains the supplementary crystallographic data for this paper. The data can be obtained free of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/structures
  • 20 Buchman CD, Hurley TD. J. Med. Chem. 2017; 60: 2439
  • 21 Yue H, Hu Z, Hu R, Guo Z, Zheng Y, Wang Y, Zhou Y. Front. Oncol. 2022; 12: 918778
    • 22a McDowell RE, McGahon MK, Augustine J, Chen M, McGeown JG, Curtis TM. Invest. Opthalmol. Visual Sci. 2016; 57: 4762
    • 22b Karan BM, Little K, Augustine J, Stitt AW, Curtis TM. Antioxidants 2023; 12: 1466

Zoom Image
Figure 1 Biologically active β-(en)amino γ-sultims
Zoom Image
Scheme 1 Synthetic approaches toward β-enamino γ-sultims
Zoom Image
Scheme 2 Retrosynthetic disconnection for the assembly of α-phenyl β-enamino γ-sultims
Zoom Image
Scheme 3 Synthesis of benzyl sulfinyl chloride (3)
Zoom Image
Scheme 4 Coordination of LiHDMS with the sulfinyl group of the precursor 2, intermediate carbanion, and the target β-enamino γ-sultim 1
Zoom Image
Figure 2 Molecular structure of α-phenyl β-enamino γ-sultim 1c according to results of X-ray crystal-structure analysis. Thermal ellipsoids are shown at the 50% probability level.
Zoom Image
Figure 3 3D binding mode of sultim 1c in the active site of ALDH1A1